Pulmonary Cystic Fibrosis Clinical Trial
Official title:
Efficiency and Acceptability of SIMEOX® Used Autonomously at Home for Bronchial Clearance in Patients With Cystic Fibrosis: Prospective, Randomized Controlled Study
Regular bronchial clearance is essential in patients with cystic fibrosis for their bronchial health. SIMEOX® (Physio-Assist, Aix en Provence, France) is an innovative medical device for the drainage of the bronchial tree. By changing the rheological properties of mucus, SIMEOX® helps to mobilize secretions and assists their transport to the upper airways. This technology is based on fundamental research on bronchial mucus rheology. At the present time, SIMEOX® device is mainly used over a short period at the time or after an exacerbation in healthcare structures (hospitals, physiotherapy practices, post-care, and rehabilitation units, etc…). The clinical effects observed in the short term encourages long-term autonomous use by the patients themselves. The overall objective of this study is to evaluate the efficiency and acceptability of SIMEOX® used at home by the patient himself for bronchial clearance in patients with cystic fibrosis.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02566044 -
Safety, Pharmacokinetics and Pharmacodynamics Study of Inhaled QBW276 in Patients With Cystic Fibrosis
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04700358 -
Characterization of Antibacterial Antibodies in Patients With Cystic Fibrosis
|
||
| Recruiting |
NCT04157361 -
Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis.
|
||
| Completed |
NCT04095078 -
Ancillary Home Airway Clearance in CF Patients ( HomeCareSIMEOX )
|
N/A | |
| Completed |
NCT02781610 -
Standardized Treatment of Pulmonary Exacerbations II
|
Phase 4 | |
| Completed |
NCT02853175 -
Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis
|